Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the five ratings firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating and four have issued a buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $16.00.
A number of equities research analysts recently weighed in on the stock. Barclays raised their target price on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Cantor Fitzgerald reissued an “overweight” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research note on Friday, March 27th. Wall Street Zen raised shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Wells Fargo & Company initiated coverage on shares of Anteris Technologies Global in a research report on Wednesday, March 11th. They set an “overweight” rating and a $16.00 price objective on the stock. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th.
Get Our Latest Research Report on Anteris Technologies Global
Anteris Technologies Global Price Performance
Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last issued its quarterly earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. The business had revenue of $0.49 million for the quarter, compared to the consensus estimate of $0.77 million. During the same quarter last year, the business posted ($0.61) EPS. On average, equities research analysts expect that Anteris Technologies Global will post -1.14 EPS for the current fiscal year.
Insider Buying and Selling
In other news, Director Susan Elizabeth Knight bought 11,000 shares of Anteris Technologies Global stock in a transaction that occurred on Tuesday, June 2nd. The shares were acquired at an average price of $9.29 per share, with a total value of $102,190.00. Following the completion of the purchase, the director directly owned 11,000 shares in the company, valued at $102,190. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 4.50% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Anteris Technologies Global
Hedge funds and other institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. increased its position in shares of Anteris Technologies Global by 76.9% during the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock valued at $29,000 after purchasing an additional 2,841 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Anteris Technologies Global in the 1st quarter worth approximately $32,000. BNP Paribas Financial Markets boosted its stake in Anteris Technologies Global by 83.3% in the third quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock worth $43,000 after buying an additional 4,302 shares in the last quarter. Bank of America Corp DE boosted its stake in Anteris Technologies Global by 35.7% in the third quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after buying an additional 2,798 shares in the last quarter. Finally, Duncan Williams Asset Management LLC bought a new position in Anteris Technologies Global during the fourth quarter valued at approximately $54,000.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Featured Articles
- Five stocks we like better than Anteris Technologies Global
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
